Bridgepoint to acquire RoC Skincare
The strategic investment in RoC builds on the firm’s growing track record of supporting businesses in the wider dermatology ecosystem, including HTL, a leading producer of high-quality hyaluronic acid, and Vivacy, a global personal healthcare company
Bridgepoint has announced a strategic investment in RoC Skincare (RoC) from the brand’s existing backer, Gryphon Investors for an undisclosed amount.